Living Well With Kidney Disease and Effective Symptom Management : Consensus Conference Proceedings
© 2022 Published by Elsevier, Inc., on behalf of the International Society of Nephrology..
Chronic kidney disease (CKD) confers a high burden of uremic symptoms that may be underrecognized, underdiagnosed, and undertreated. Unpleasant symptoms, such as CKD-associated pruritus and emotional/psychological distress, often occur within symptom clusters, and treating 1 symptom may potentially alleviate other symptoms in that cluster. The Living Well with Kidney Disease and Effective Symptom Management Consensus Conference convened health experts and leaders of kidney advocacy groups and kidney networks worldwide to discuss the effects of unpleasant symptoms related to CKD on the health and well-being of those affected, and to consider strategies for optimal symptom management. Optimizing symptom management is a cornerstone of conservative and preservative management which aim to prevent or delay dialysis initiation. In persons with kidney dysfunction requiring dialysis (KDRD), incremental transition to dialysis and home dialysis modalities offer personalized approaches. KDRD is proposed as the preferred term given the negative connotations of "failure" as a kidney descriptor, and the success stories in CKD journeys. Engaging persons with CKD to identify and prioritize their personal values and individual needs must be central to ensure their active participation in CKD management, including KDRD. Person-centered communication and care are required to ensure diversity, equity, and inclusion; education/awareness that considers the health literacy of persons with CKD; and shared decision-making among the person with CKD, care partners, and providers. By putting the needs of people with CKD, including effective symptom management, at the center of their treatment, CKD can be optimally treated in a way that aligns with their goals.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Kidney international reports - 7(2022), 9 vom: 15. Sept., Seite 1951-1963 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rhee, Connie M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chronic kidney disease |
|---|
| Anmerkungen: |
Date Revised 17.02.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.ekir.2022.06.015 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346074738 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346074738 | ||
| 003 | DE-627 | ||
| 005 | 20231226030548.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ekir.2022.06.015 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1153.xml |
| 035 | |a (DE-627)NLM346074738 | ||
| 035 | |a (NLM)36090498 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rhee, Connie M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Living Well With Kidney Disease and Effective Symptom Management |b Consensus Conference Proceedings |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.02.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2022 Published by Elsevier, Inc., on behalf of the International Society of Nephrology. | ||
| 520 | |a Chronic kidney disease (CKD) confers a high burden of uremic symptoms that may be underrecognized, underdiagnosed, and undertreated. Unpleasant symptoms, such as CKD-associated pruritus and emotional/psychological distress, often occur within symptom clusters, and treating 1 symptom may potentially alleviate other symptoms in that cluster. The Living Well with Kidney Disease and Effective Symptom Management Consensus Conference convened health experts and leaders of kidney advocacy groups and kidney networks worldwide to discuss the effects of unpleasant symptoms related to CKD on the health and well-being of those affected, and to consider strategies for optimal symptom management. Optimizing symptom management is a cornerstone of conservative and preservative management which aim to prevent or delay dialysis initiation. In persons with kidney dysfunction requiring dialysis (KDRD), incremental transition to dialysis and home dialysis modalities offer personalized approaches. KDRD is proposed as the preferred term given the negative connotations of "failure" as a kidney descriptor, and the success stories in CKD journeys. Engaging persons with CKD to identify and prioritize their personal values and individual needs must be central to ensure their active participation in CKD management, including KDRD. Person-centered communication and care are required to ensure diversity, equity, and inclusion; education/awareness that considers the health literacy of persons with CKD; and shared decision-making among the person with CKD, care partners, and providers. By putting the needs of people with CKD, including effective symptom management, at the center of their treatment, CKD can be optimally treated in a way that aligns with their goals | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a chronic kidney disease | |
| 650 | 4 | |a conservative management | |
| 650 | 4 | |a person-centered care | |
| 650 | 4 | |a quality of life | |
| 650 | 4 | |a symptom clusters | |
| 650 | 4 | |a unpleasant symptoms | |
| 700 | 1 | |a Edwards, Dawn |e verfasserin |4 aut | |
| 700 | 1 | |a Ahdoot, Rebecca S |e verfasserin |4 aut | |
| 700 | 1 | |a Burton, James O |e verfasserin |4 aut | |
| 700 | 1 | |a Conway, Paul T |e verfasserin |4 aut | |
| 700 | 1 | |a Fishbane, Steven |e verfasserin |4 aut | |
| 700 | 1 | |a Gallego, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Gallieni, Maurizio |e verfasserin |4 aut | |
| 700 | 1 | |a Gedney, Nieltje |e verfasserin |4 aut | |
| 700 | 1 | |a Hayashida, Glen |e verfasserin |4 aut | |
| 700 | 1 | |a Ingelfinger, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Kataoka-Yahiro, Merle |e verfasserin |4 aut | |
| 700 | 1 | |a Knight, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Kopple, Joel D |e verfasserin |4 aut | |
| 700 | 1 | |a Kumarsawami, Latha |e verfasserin |4 aut | |
| 700 | 1 | |a Lockwood, Mark B |e verfasserin |4 aut | |
| 700 | 1 | |a Murea, Mariana |e verfasserin |4 aut | |
| 700 | 1 | |a Page, Victoria |e verfasserin |4 aut | |
| 700 | 1 | |a Sanchez, J Emilio |e verfasserin |4 aut | |
| 700 | 1 | |a Szepietowski, Jacek C |e verfasserin |4 aut | |
| 700 | 1 | |a Lui, Siu-Fai |e verfasserin |4 aut | |
| 700 | 1 | |a Kalantar-Zadeh, Kamyar |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Kidney international reports |d 2016 |g 7(2022), 9 vom: 15. Sept., Seite 1951-1963 |w (DE-627)NLM264185072 |x 2468-0249 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2022 |g number:9 |g day:15 |g month:09 |g pages:1951-1963 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ekir.2022.06.015 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2022 |e 9 |b 15 |c 09 |h 1951-1963 | ||